This study highlights the potential of using XV, an advanced functional imaging tool, to better understand regional lung function and optimize the therapeutic application of Non-Invasive Positive Pressure Ventilation (NIPPV). These insights could pave the way for improved patient outcomes for individuals with respiratory conditions, by tailoring interventions to improve

4DMedical has won a contract with the United States Department of Defense (DoD) to pilot its CT Ventilation-Perfusion (CT:VQ™) technology to assess lung health in a fixed cohort of active duty personnel. This contract builds on the success of 4DMedical's earlier agreement with the DoD for the deployment of its

4DMedical has received clearance from the U.S. Food and Drug Administration (FDA) for its IQ-UIP™ product, an advanced AI-driven lung diagnostic tool designed to revolutionize the diagnosis of Usual Interstitial Pneumonia (UIP), the hallmark radiological pattern for diagnosing Interstitial Pulmonary Fibrosis (IPF).